X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with Merck Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs MERCK LTD - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD MERCK LTD WYETH LTD/
MERCK LTD
 
P/E (TTM) x 27.7 34.4 80.7% View Chart
P/BV x 5.3 3.8 139.0% View Chart
Dividend Yield % 1.3 0.7 173.2%  

Financials

 WYETH LTD   MERCK LTD
EQUITY SHARE DATA
    WYETH LTD
Mar-13
MERCK LTD
Dec-16
WYETH LTD/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs1,0441,060 98.5%   
Low Rs818623 131.3%   
Sales per share (Unadj.) Rs298.6632.4 47.2%  
Earnings per share (Unadj.) Rs57.245.7 125.2%  
Cash flow per share (Unadj.) Rs58.462.3 93.7%  
Dividends per share (Unadj.) Rs17.0011.00 154.5%  
Dividend yield (eoy) %1.81.3 139.7%  
Book value per share (Unadj.) Rs249.5388.8 64.2%  
Shares outstanding (eoy) m22.7216.60 136.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.11.3 234.4%   
Avg P/E ratio x16.318.4 88.4%  
P/CF ratio (eoy) x15.913.5 118.1%  
Price / Book Value ratio x3.72.2 172.5%  
Dividend payout %29.724.1 123.4%   
Avg Mkt Cap Rs m21,15713,969 151.5%   
No. of employees `0000.51.6 31.1%   
Total wages/salary Rs m4001,487 26.9%   
Avg. sales/employee Rs Th13,787.46,631.9 207.9%   
Avg. wages/employee Rs Th813.0939.2 86.6%   
Avg. net profit/employee Rs Th2,643.3479.4 551.4%   
INCOME DATA
Net Sales Rs m6,78310,498 64.6%  
Other income Rs m353242 145.5%   
Total revenues Rs m7,13610,741 66.4%   
Gross profit Rs m1,6171,135 142.5%  
Depreciation Rs m27276 9.7%   
Interest Rs m60-   
Profit before tax Rs m1,9381,102 175.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m632343 184.2%   
Profit after tax Rs m1,301759 171.4%  
Gross profit margin %23.810.8 220.5%  
Effective tax rate %32.631.1 104.7%   
Net profit margin %19.27.2 265.2%  
BALANCE SHEET DATA
Current assets Rs m6,9846,410 109.0%   
Current liabilities Rs m2,0568,828 23.3%   
Net working cap to sales %72.6-23.0 -315.3%  
Current ratio x3.40.7 467.9%  
Inventory Days Days9958 172.1%  
Debtors Days Days2438 62.4%  
Net fixed assets Rs m2441,406 17.4%   
Share capital Rs m227166 136.9%   
"Free" reserves Rs m5,4416,286 86.6%   
Net worth Rs m5,6686,455 87.8%   
Long term debt Rs m250-   
Total assets Rs m7,9018,828 89.5%  
Interest coverage x353.3NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.91.2 72.2%   
Return on assets %16.58.6 192.3%  
Return on equity %22.911.8 195.1%  
Return on capital %34.017.1 199.4%  
Exports to sales %0.28.3 2.6%   
Imports to sales %36.321.0 172.7%   
Exports (fob) Rs m15869 1.7%   
Imports (cif) Rs m2,4652,209 111.6%   
Fx inflow Rs m15959 1.6%   
Fx outflow Rs m2,6772,612 102.5%   
Net fx Rs m-2,662-1,653 161.0%   
CASH FLOW
From Operations Rs m9231,070 86.2%  
From Investments Rs m317-750 -42.3%  
From Financial Activity Rs m-481-150 321.1%  
Net Cashflow Rs m759171 444.2%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.1 51.8 98.6%  
Indian inst/Mut Fund % 11.3 18.2 62.1%  
FIIs % 7.2 1.0 720.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 29.1 104.5%  
Shareholders   21,978 28,591 76.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   SHASUN PHARMA  CIPLA  DR. DATSONS LABS  ORCHID PHARMA LTD  GSK PHARMA  

Compare WYETH LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Strong; Metal, Pharma Stocks Lead Gains(01:30 pm)

After opening the day in green, share markets in India have continued the momentum and are presently trading above the dotted line.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WYETH LTD WITH

MARKET STATS